Hirokazu Taniguchi
- Oncology top 5%
- Lung Cancer Research Studies 19
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Research top 10%
-
- Lung Cancer Treatments and Mutations 18
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Metastasis and carcinoma case studies 7
-
- Neuroendocrine Tumor Research Advances 10
- Co-authors
- Hiroyuki AburataniHiroshi MukaeYuichi SugiyamaDaisuke SugiyamaShumpei IshikawaYoshitane NozakiHiroyuki KusuharaTriparna Sen
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hirokazu Taniguchi
98 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 111
- Oncology 697
- Cancer Research 225
- Pulmonary and Respiratory Medicine 382
- Endocrinology, Diabetes and Metabolism 150
- Molecular Biology 596
Countries citing papers authored by Hirokazu Taniguchi
This map shows the geographic impact of Hirokazu Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Taniguchi more than expected).
Fields of papers citing papers by Hirokazu Taniguchi
This network shows the impact of papers produced by Hirokazu Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Taniguchi. The network helps show where Hirokazu Taniguchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirokazu Taniguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 81 | |
| 7 | 2022 | 8 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 79 | |
| 12 | 2019 | 3 | |
| 13 | 2017 | 31 | |
| 14 | 2016 | 2 | |
| 15 | 2011 | 22 | |
| 16 | 2008 | 0 | |
| 17 | 2004 | 1 | |
| 18 | 2003 | 0 | |
| 19 | 2000 | 28 | |
| 20 | 1999 | 27 |
About Hirokazu Taniguchi
Hirokazu Taniguchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 109 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (19 papers), Lung Cancer Treatments and Mutations (18 papers), Neuroendocrine Tumor Research Advances (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Metastasis and carcinoma case studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (697 citations), Cancer Research (225 citations) and Pulmonary and Respiratory Medicine (382 citations). Hirokazu Taniguchi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroyuki Aburatani, Hiroshi Mukae, Yuichi Sugiyama, Daisuke Sugiyama, Shumpei Ishikawa, Yoshitane Nozaki, Hiroyuki Kusuhara, Triparna Sen, Charles M. Rudin and S Kohno. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.